Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

GENinCode

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.
2018
11-50
Oxford, Oxfordshire, United Kingdom
BiotechnologynologyHealth CareLife SciencePrecision Medicine

Investment Funding

Last Funding Stage

Post-IPO Equity

Total Funding Amount

10.26M

Last Funding Amount

5.07M

Last Funding Date

21-12-2023

Startup Stage

IPO

Lead Investors

Maven Capital Partners

Revenue

$1M to $10M

People

Founders